Tenaya therapeutics announces publication of preclinical hdac6 inhibitor data for heart failure with preserved ejection fraction in nature communications

Highly selective small molecule hdac6 inhibitor effectively reversed heart failure and improved diastolic heart function alone or in combination with sglt2 inhibitor in murine models of disease

TNYA Ratings Summary

TNYA Quant Ranking